About this Journal Submit a Manuscript Table of Contents
Experimental Diabetes Research
Volume 2012 (2012), Article ID 414893, 5 pages
http://dx.doi.org/10.1155/2012/414893
Research Article

Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences

1Department of Internal Medicine and Gastroenterology, University Hospital and Faculty of Medicine, Masaryk University Brno, Jihlavska 20 62500 Brno, Czech Republic
2University of North Dakota, Grand Forks, ND 58202, USA
3Department of Pathology, University Hospital and Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic

Received 20 December 2011; Revised 21 March 2012; Accepted 8 May 2012

Academic Editor: Chin-Hsiao Tseng

Copyright © 2012 Jan Trna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Bramhall, W. H. Allum, A. G. Jones, A. Allwood, C. Cummins, and J. P. Neoptolemos, “Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study,” British Journal of Surgery, vol. 82, no. 1, pp. 111–115, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Fernandez, C. La Vecchia, M. Porta, E. Negri, F. Lucchini, and F. Levi, “Trends in pancreatic cancer mortality in Europe, 1955-1989,” International Journal of Cancer, vol. 57, no. 6, pp. 786–792, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Hruban, N. V. Adsay, J. Albores-Saavedra, et al., “The genetic basis of human cancer,” in Pancreatic Cancer, B. Vogelstein and K. W. Kinzler, Eds., pp. 603–613, Mc Graw-Hill, New York, NY, USA, 1996.
  4. A. Jemal, T. Murray, E. Ward, and A. Samuels, “Cancer statistics,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 4, pp. 10–30, 2005. View at Scopus
  5. M. Canto, M. Goggins, C. J. Yeo et al., “Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach,” Clinical Gastroenterology and Hepatology, vol. 2, no. 7, pp. 606–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Kessler, “Cancer mortality among diabetics,” Journal of the National Cancer Institute, vol. 44, no. 3, pp. 673–686, 1970. View at Scopus
  7. M. W. Ragozzino, L. J. Melton 3rd, C. P. Chu, and P. J. Palumbo, “Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus,” Journal of Chronic Diseases, vol. 35, no. 1, pp. 13–19, 1982. View at Scopus
  8. L. Wideroff, G. Gridley, L. Mellemkjaer et al., “Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark,” Journal of the National Cancer Institute, vol. 89, no. 18, pp. 1360–1365, 1997. View at Scopus
  9. D. T. Silverman, M. Schiffman, J. Everhart et al., “Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer,” British Journal of Cancer, vol. 80, no. 11, pp. 1830–1837, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Bonelli, H. Aste, P. Bovo et al., “Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in Northern Italy,” Pancreas, vol. 27, no. 2, pp. 143–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. T. Chari, C. L. Leibson, M. de Andrade, K. G. Rabe, J. Ransom, and G. M. Petersen, “Probability of pancreatic cancer following diabetes: a population-based study,” Gastroenterology, vol. 129, no. 2, pp. 504–511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ogawa, M. Tanaka, K. Inoue et al., “A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus,” Cancer, vol. 94, no. 9, pp. 2344–2349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Pannala, A. Basu, G. M. Petersen, and S. T. Chari, “New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer,” The Lancet Oncology, vol. 10, no. 1, pp. 88–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Li, K. Xie, R. Wolff, and J. L. Abbruzzese, “Pancreatic cancer,” The Lancet, vol. 363, no. 9414, pp. 1049–1057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. B. Lowenfels, P. Maisonneuve, E. P. DiMagno et al., “Hereditary pancreatitis and the risk of pancreatic cancer,” Journal of the National Cancer Institute, vol. 89, no. 6, pp. 442–446, 1997. View at Scopus
  16. S. A. Hahn, B. Greenhalf, I. Ellis et al., “BRCA2 germline mutations in familial pancreatic carcinoma,” Journal of the National Cancer Institute, vol. 95, no. 3, pp. 214–221, 2003. View at Scopus
  17. A. M. Goldstein, M. C. Fraser, J. P. Struewing et al., “Increased risk of pancreatic cancer in melanoma-prone kindreds with p16(INK4) mutations,” The New England Journal of Medicine, vol. 333, no. 15, pp. 970–974, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. F. M. Giardiello, J. D. Brensinger, A. C. Tersmette et al., “Very high risk of cancer in familial Peutz-Jeghers syndrome,” Gastroenterology, vol. 119, no. 6, pp. 1447–1453, 2000. View at Scopus
  19. A. P. Klein, K. A. Brune, G. M. Petersen et al., “Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds,” Cancer Research, vol. 64, no. 7, pp. 2634–2638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. T. Chari, “Detecting pancreatic cancer early: problems and prospects,” Seminars in Oncology, vol. 34, no. 4, pp. 284–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Ben, M. Xu, X. Ning et al., “Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies,” European Journal of Cancer, vol. 47, no. 13, pp. 1928–1937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Pannala, J. B. Leirness, W. R. Bamlet, A. Basu, G. M. Petersen, and S. T. Chari, “Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus,” Gastroenterology, vol. 134, no. 4, pp. 981–987, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Chari, C. L. Leibson, K. G. Rabe et al., “Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer,” Gastroenterology, vol. 134, no. 1, pp. 95–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Maisonneuve, A. B. Lowenfels, H. B. Bueno-de-Mesquita et al., “Past medical history and pancreatic cancer risk: results from a multicenter case-control study,” Annals of Epidemiology, vol. 20, no. 2, pp. 92–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. I. Harris, R. Klein, T. A. Welborn, and M. W. Knuiman, “Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis,” Diabetes Care, vol. 15, no. 7, pp. 815–819, 1992. View at Scopus
  26. C. C. Cowie, K. F. Rust, E. S. Ford et al., “Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006,” Diabetes Care, vol. 32, no. 2, pp. 287–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Wittek, B. Sokalski, W. Grzeszczak, and K. Strojek, “Prevalence of diabetes and cardiovascular risk factors of industrial area in Southern Poland,” Experimental and Clinical Endocrinology and Diabetes, vol. 117, no. 7, pp. 350–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. M. Cheung, K. L. Ong, S. S. Cherny, P. C. Sham, A. W. Tso, and K. S. Lam, “Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006,” American Journal of Medicine, vol. 122, no. 5, pp. 443–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. Souza, M. C. Machado, J. E. Cunha et al., “Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration,” Pancreatology, vol. 7, no. 2-3, pp. 187–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Gullo, R. Pezzilli, and A. M. Morselli-Labate, “Diabetes and the risk of pancreatic cancer,” The New England Journal of Medicine, vol. 331, no. 2, pp. 81–84, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Everhart and D. Wright, “Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis,” Journal of the American Medical Association, vol. 273, no. 20, pp. 1605–1609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Noy and J. P. Bilezikian, “Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 5, pp. 1223–1231, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. H. O. Adami, S. McLaughlin, and A. Ekban, “Cancer risk in patients with diabetes mellitus,” Cancer Causes and Control, vol. 2, no. 5, pp. 307–314, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Pelaez-Luna, N. Takahashi, J. G. Fletcher, and S. T. Chari, “Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis,” American Journal of Gastroenterology, vol. 102, no. 10, pp. 2157–2163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Gangi, J. G. Fletcher, M. A. Nathan et al., “Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis,” American Journal of Roentgenology, vol. 182, no. 4, pp. 897–903, 2004. View at Scopus
  36. J. Damiano, L. Bordier, J. P. Le Berre et al., “Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?” Diabetes and Metabolism, vol. 30, no. 2, pp. 203–207, 2004. View at Scopus
  37. S. Chakraborty, M. J. Baine, A. R. Sasson, and S. K. Batra, “Current status of molecular markers for early detection of sporadic pancreatic cancer,” Biochimica et Biophysica Acta, vol. 1815, no. 1, pp. 44–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. T. Magruder, D. Elahi, and D. K. Andersen, “Diabetes and pancreatic cancer: chicken or egg?” Pancreas, vol. 40, no. 3, pp. 339–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Dítě and E. Geryk, “Trends of primary and subsequent cancers of the gastrointestinal tract in the Czech population, 1976-2005,” Digestive Diseases, vol. 28, no. 4-5, pp. 657–669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Geryk, P. Dite, J. Trna, et al., “Pancreas cancer burden of the Czech population,” Onkologie, vol. 4, pp. 322–325, 2010.